The House resumed from January 31 consideration of Bill C-393, An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act, as reported (with amendment) from the committee, and of the motions in Group No. 1.
In the House of Commons on March 3rd, 2011. See this statement in context.